Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2017 | Pages:
97 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the United States Leukocyte Surface Antigen CD47 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Leukocyte Surface Antigen CD47 in these regions, from 2012 to 2022 (forecast).
United States Leukocyte Surface Antigen CD47 market competition by top manufacturers/players, with Leukocyte Surface Antigen CD47 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Aurigene Discovery Technologies Ltd
Celgene Corp
Forty Seven Inc
Surface Oncology Inc
Trillium Therapeutics Inc
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
B-6H12
ALX-148
CC-90002
PSTx-23
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Lymphoma
Ovarian Cancer
Ischemia Reperfusion Injury
Kindney Transplant Rejection
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Leukocyte Surface Antigen CD47 Market Report 2017
1 Leukocyte Surface Antigen CD47 Overview
1.1 Product Overview and Scope of Leukocyte Surface Antigen CD47
1.2 Classification of Leukocyte Surface Antigen CD47 by Product Category
1.2.1 United States Leukocyte Surface Antigen CD47 Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Leukocyte Surface Antigen CD47 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 B-6H12
1.2.4 ALX-148
1.2.5 CC-90002
1.2.6 PSTx-23
1.2.7 Others
1.3 United States Leukocyte Surface Antigen CD47 Market by Application/End Users
1.3.1 United States Leukocyte Surface Antigen CD47 Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Lymphoma
1.3.3 Ovarian Cancer
1.3.4 Ischemia Reperfusion Injury
1.3.5 Kindney Transplant Rejection
1.3.6 Others
1.4 United States Leukocyte Surface Antigen CD47 Market by Region
1.4.1 United States Leukocyte Surface Antigen CD47 Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Leukocyte Surface Antigen CD47 Status and Prospect (2012-2022)
1.4.3 Southwest Leukocyte Surface Antigen CD47 Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Leukocyte Surface Antigen CD47 Status and Prospect (2012-2022)
1.4.5 New England Leukocyte Surface Antigen CD47 Status and Prospect (2012-2022)
1.4.6 The South Leukocyte Surface Antigen CD47 Status and Prospect (2012-2022)
1.4.7 The Midwest Leukocyte Surface Antigen CD47 Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Leukocyte Surface Antigen CD47 (2012-2022)
1.5.1 United States Leukocyte Surface Antigen CD47 Sales and Growth Rate (2012-2022)
1.5.2 United States Leukocyte Surface Antigen CD47 Revenue and Growth Rate (2012-2022)
2 United States Leukocyte Surface Antigen CD47 Market Competition by Players/Suppliers
2.1 United States Leukocyte Surface Antigen CD47 Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Leukocyte Surface Antigen CD47 Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Leukocyte Surface Antigen CD47 Average Price by Players/Suppliers (2012-2017)
2.4 United States Leukocyte Surface Antigen CD47 Market Competitive Situation and Trends
2.4.1 United States Leukocyte Surface Antigen CD47 Market Concentration Rate
2.4.2 United States Leukocyte Surface Antigen CD47 Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Leukocyte Surface Antigen CD47 Manufacturing Base Distribution, Sales Area, Product Type
3 United States Leukocyte Surface Antigen CD47 Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Leukocyte Surface Antigen CD47 Sales and Market Share by Region (2012-2017)
3.2 United States Leukocyte Surface Antigen CD47 Revenue and Market Share by Region (2012-2017)
3.3 United States Leukocyte Surface Antigen CD47 Price by Region (2012-2017)
4 United States Leukocyte Surface Antigen CD47 Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Leukocyte Surface Antigen CD47 Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Leukocyte Surface Antigen CD47 Revenue and Market Share by Type (2012-2017)
4.3 United States Leukocyte Surface Antigen CD47 Price by Type (2012-2017)
4.4 United States Leukocyte Surface Antigen CD47 Sales Growth Rate by Type (2012-2017)
5 United States Leukocyte Surface Antigen CD47 Sales (Volume) by Application (2012-2017)
5.1 United States Leukocyte Surface Antigen CD47 Sales and Market Share by Application (2012-2017)
5.2 United States Leukocyte Surface Antigen CD47 Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Leukocyte Surface Antigen CD47 Players/Suppliers Profiles and Sales Data
6.1 Aurigene Discovery Technologies Ltd
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Leukocyte Surface Antigen CD47 Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Celgene Corp
6.2.2 Leukocyte Surface Antigen CD47 Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Forty Seven Inc
6.3.2 Leukocyte Surface Antigen CD47 Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Surface Oncology Inc
6.4.2 Leukocyte Surface Antigen CD47 Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Trillium Therapeutics Inc
6.5.2 Leukocyte Surface Antigen CD47 Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
...
7 Leukocyte Surface Antigen CD47 Manufacturing Cost Analysis
7.1 Leukocyte Surface Antigen CD47 Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Leukocyte Surface Antigen CD47
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Leukocyte Surface Antigen CD47 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Leukocyte Surface Antigen CD47 Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Leukocyte Surface Antigen CD47 Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Leukocyte Surface Antigen CD47 Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Leukocyte Surface Antigen CD47 Sales Volume Forecast by Type (2017-2022)
11.3 United States Leukocyte Surface Antigen CD47 Sales Volume Forecast by Application (2017-2022)
11.4 United States Leukocyte Surface Antigen CD47 Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Leukocyte Surface Antigen CD47
Figure United States Leukocyte Surface Antigen CD47 Market Size (K Pcs) by Type (2012-2022)
Figure United States Leukocyte Surface Antigen CD47 Sales Volume Market Share by Type (Product Category) in 2016
Figure B-6H12 Product Picture
Figure ALX-148 Product Picture
Figure CC-90002 Product Picture
Figure PSTx-23 Product Picture
Figure Others Product Picture
Figure United States Leukocyte Surface Antigen CD47 Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Leukocyte Surface Antigen CD47 by Application in 2016
Figure Lymphoma Examples
Table Key Downstream Customer in Lymphoma
Figure Ovarian Cancer Examples
Table Key Downstream Customer in Ovarian Cancer
Figure Ischemia Reperfusion Injury Examples
Table Key Downstream Customer in Ischemia Reperfusion Injury
Figure Kindney Transplant Rejection Examples
Table Key Downstream Customer in Kindney Transplant Rejection
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Leukocyte Surface Antigen CD47 Market Size (Million USD) by Region (2012-2022)
Figure The West Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Leukocyte Surface Antigen CD47 Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Leukocyte Surface Antigen CD47 Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Leukocyte Surface Antigen CD47 Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Leukocyte Surface Antigen CD47 Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Leukocyte Surface Antigen CD47 Sales Share by Players/Suppliers
Figure 2017 United States Leukocyte Surface Antigen CD47 Sales Share by Players/Suppliers
Figure United States Leukocyte Surface Antigen CD47 Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Leukocyte Surface Antigen CD47 Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Leukocyte Surface Antigen CD47 Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Leukocyte Surface Antigen CD47 Revenue Share by Players/Suppliers
Figure 2017 United States Leukocyte Surface Antigen CD47 Revenue Share by Players/Suppliers
Table United States Market Leukocyte Surface Antigen CD47 Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Leukocyte Surface Antigen CD47 Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Leukocyte Surface Antigen CD47 Market Share of Top 3 Players/Suppliers
Figure United States Leukocyte Surface Antigen CD47 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Leukocyte Surface Antigen CD47 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Leukocyte Surface Antigen CD47 Product Category
Table United States Leukocyte Surface Antigen CD47 Sales (K Pcs) by Region (2012-2017)
Table United States Leukocyte Surface Antigen CD47 Sales Share by Region (2012-2017)
Figure United States Leukocyte Surface Antigen CD47 Sales Share by Region (2012-2017)
Figure United States Leukocyte Surface Antigen CD47 Sales Market Share by Region in 2016
Table United States Leukocyte Surface Antigen CD47 Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Leukocyte Surface Antigen CD47 Revenue Share by Region (2012-2017)
Figure United States Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2012-2017)
Figure United States Leukocyte Surface Antigen CD47 Revenue Market Share by Region in 2016
Table United States Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Region (2012-2017)
Table United States Leukocyte Surface Antigen CD47 Sales (K Pcs) by Type (2012-2017)
Table United States Leukocyte Surface Antigen CD47 Sales Share by Type (2012-2017)
Figure United States Leukocyte Surface Antigen CD47 Sales Share by Type (2012-2017)
Figure United States Leukocyte Surface Antigen CD47 Sales Market Share by Type in 2016
Table United States Leukocyte Surface Antigen CD47 Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Leukocyte Surface Antigen CD47 Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Leukocyte Surface Antigen CD47 by Type (2012-2017)
Figure Revenue Market Share of Leukocyte Surface Antigen CD47 by Type in 2016
Table United States Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Types (2012-2017)
Figure United States Leukocyte Surface Antigen CD47 Sales Growth Rate by Type (2012-2017)
Table United States Leukocyte Surface Antigen CD47 Sales (K Pcs) by Application (2012-2017)
Table United States Leukocyte Surface Antigen CD47 Sales Market Share by Application (2012-2017)
Figure United States Leukocyte Surface Antigen CD47 Sales Market Share by Application (2012-2017)
Figure United States Leukocyte Surface Antigen CD47 Sales Market Share by Application in 2016
Table United States Leukocyte Surface Antigen CD47 Sales Growth Rate by Application (2012-2017)
Figure United States Leukocyte Surface Antigen CD47 Sales Growth Rate by Application (2012-2017)
Table Aurigene Discovery Technologies Ltd Basic Information List
Table Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales Growth Rate (2012-2017)
Figure Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales Market Share in United States (2012-2017)
Figure Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Revenue Market Share in United States (2012-2017)
Table Celgene Corp Basic Information List
Table Celgene Corp Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celgene Corp Leukocyte Surface Antigen CD47 Sales Growth Rate (2012-2017)
Figure Celgene Corp Leukocyte Surface Antigen CD47 Sales Market Share in United States (2012-2017)
Figure Celgene Corp Leukocyte Surface Antigen CD47 Revenue Market Share in United States (2012-2017)
Table Forty Seven Inc Basic Information List
Table Forty Seven Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Forty Seven Inc Leukocyte Surface Antigen CD47 Sales Growth Rate (2012-2017)
Figure Forty Seven Inc Leukocyte Surface Antigen CD47 Sales Market Share in United States (2012-2017)
Figure Forty Seven Inc Leukocyte Surface Antigen CD47 Revenue Market Share in United States (2012-2017)
Table Surface Oncology Inc Basic Information List
Table Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales Growth Rate (2012-2017)
Figure Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales Market Share in United States (2012-2017)
Figure Surface Oncology Inc Leukocyte Surface Antigen CD47 Revenue Market Share in United States (2012-2017)
Table Trillium Therapeutics Inc Basic Information List
Table Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales Growth Rate (2012-2017)
Figure Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales Market Share in United States (2012-2017)
Figure Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Leukocyte Surface Antigen CD47
Figure Manufacturing Process Analysis of Leukocyte Surface Antigen CD47
Figure Leukocyte Surface Antigen CD47 Industrial Chain Analysis
Table Raw Materials Sources of Leukocyte Surface Antigen CD47 Major Players/Suppliers in 2016
Table Major Buyers of Leukocyte Surface Antigen CD47
Table Distributors/Traders List
Figure United States Leukocyte Surface Antigen CD47 Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Leukocyte Surface Antigen CD47 Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Leukocyte Surface Antigen CD47 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Leukocyte Surface Antigen CD47 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Leukocyte Surface Antigen CD47 Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Leukocyte Surface Antigen CD47 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Leukocyte Surface Antigen CD47 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Leukocyte Surface Antigen CD47 Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Leukocyte Surface Antigen CD47 Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Leukocyte Surface Antigen CD47 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Leukocyte Surface Antigen CD47 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Leukocyte Surface Antigen CD47 Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
